PSPH and glioblastoma: Collectively, alterations have been found in ~35% of lung cancers, in ~37% of melanomas, and 25% of glioblastoma (GBM) patients, in the latter with recurrent amplifications of PSPH gene in 12% of cases (TCGA copy number portal, p = 5.25 × 10−61) [40,41].